Skeptics in the Pub, Oxford
Thinking and drinking. That is the unlikely goal of our meeting. Each month we invite a speaker to talk about an area of belief and to invite critical debate. We encourage sceptical thought and we enjoy challenging discussions. We also welcome humour and we intend to have a good time.
The meetings are open to all, no matter what your prior beliefs. We ask that you come along with a willingness to be challenged in your beliefs and we provide an opportuity for you to challenge others - and to enjoy a drink or two.
Follow us on Facebook and Twitter.
Subscribe to the podcast with iTunes:
Direct link to the podcast feed:
Our next topic is...
Wednesday, July 8 2015 at 7:30PM
Download iCalendar file
(e.g. import to Outlook or Google Calendar)
Wig and Pen
9 - 13 George Street
We use the upstairs function room.
To find it, go up the spiral staircase - then look for the door immediately opposite you. Go through, up another flight of stairs and you will find us. There is a bar up here and it will be open, so no need to spill your pint on the spiral stairs. If you want to eat in the function room then you have to order your food downstairs and then carry it up yourself.
Step-free access is available.
Professor Carl Heneghan
What's the talk about?
The AllTrials campaign calls for all past and present clinical trials to be registered and their full methods and summary results to be reported - half of all trials go unpublished. The AllTrials petition has been signed by 84,879 people and 574 organisations. A co-founder of the popular initiative, Professor Carl Heneghan will talk about how the campaign is making progress by leaps and bounds, and issues raised in the five years spent obtaining the unpublished evidence for Tamiflu, as well as the implications for health care and general practice in the future.
Carl Heneghan is Director of the Centre of Evidence-Based Medicine, a General Practitioner and Senior Tutor of Kellogg College. He is a clinical epidemiologist so studies patients who see clinicians, especially those with common problems. His work focuses on improving the evidence-base to change practice. His research includes the treatment of communicable diseases in primary care, including recent work on Tamiflu.